Cell Press

SHERPA: Unknown

People

  1. Vardhana
    Vardhana
  2. Intlekofer
    Intlekofer
  3. De Stanchina
    De Stanchina
  4. Lin
    Lin
  5. Asgari
    Asgari
  6. Cadete Portelinha
    Cadete Portelinha
  7. Elhanati
    Elhanati
  8. Greenbaum
    Greenbaum
  9. Horwitz
    Horwitz
  10. Huse
    Huse

Groups

  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Lymphoma (17)
  5. GSK Faculty (14)
  6. Human Oncology and Pathogenesis Program (12)
  7. Sloan Kettering Institute Postdocs (7)
  8. Center for Molecular Imaging and Biotechnology (6)
  9. Executive Committee, Center for Hematologic Malignancies (6)
  10. Center for Pancreatic Cancer Research (5)
Search Within
  1. "Lymphoma"
Formats
  1. Journal Article (11)
  2. Editorial (2)
  3. Meeting Abstract (2)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (17)
  3. Hematologic Malignancies, Division of (17)
  4. Lymphoma (17)
  5. GSK Faculty (14)
  6. Human Oncology and Pathogenesis Program (12)

More Groups

People
  1. Santosha Vardhana (8)
  2. Anas Younes (4)
  3. Andrew Intlekofer (4)
  4. Elisa De Stanchina (3)
  5. Ya-Hui Lin (3)
  6. Ana Cadete Portelinha (2)

More People

Years
  1. 2025 (2)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (2)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Cancer Cell (6)
  2. Biophysical Journal (2)
  3. Cell Reports (2)
  4. Cell Reports Medicine (2)
  5. Immunity (1)
  6. Molecular Cell (1)

More Publications

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tackling the next decade of cancer research
    Editorial

    Ali, R.; Jenkins, B.; Karthaus, W.; Lipkova, J.; Misale, S.; Puschhof, J.; Smith, M.; Vardhana, S.; Zhou, X.
    Trends in Cancer (2025)

    Fulltext@MSK | Save
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Investigating the relationship between cytotoxic T lymphocyte mechanical output and metabolism
    Meeting Abstract

    Wong, Y. Y.; de Jesus, M.; Huse, M.; Vardhana, S.
    Biophysical Journal (2023)

    Fulltext@MSK | Save
  • High-throughput interrogation of immune responses using the Human Immune Profiling Pipeline
    Journal Article

    Wang, G.; Lyudovyk, O.; Kim, J. Y.; Lin, Y. H.; Elhanati, Y.; Mathew, D.; Wherry, E. J.; Herati, R. S.; Greenplate, A. R.; Greenbaum, B.; more...
    STAR Protocols (2023)

    Fulltext@MSK | Save
  • Investigating the relationship between cytotoxic T lymphocyte mechanical output and metabolism
    Meeting Abstract

    Wong, Y. Y.; de Jesus, M.; Huse, M.; Vardhana, S.
    Biophysical Journal (2023)

    Fulltext@MSK | Save
  • D-2HG comes out of its shell: Metabolic effects on the immune environment
    Editorial

    Schvartzman, J. M.; Intlekofer, A. M.
    Molecular Cell (2022)

    Fulltext@MSK | Save
  • SARS-CoV-2 in immunocompromised individuals
    Review

    DeWolf, S.; Laracy, J. C.; Perales, M. A.; Kamboj, M.; van den Brink, M. R. M.; Vardhana, S.
    Immunity (2022)

    Fulltext@MSK | Save
  • Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
    Journal Article

    Lyudovyk, O.; Kim, J. Y.; Qualls, D.; Hwee, M. A.; Lin, Y. H.; Boutemine, S. R.; Elhanati, Y.; Solovyov, A.; Douglas, M.; Chen, E.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
    Journal Article

    Belk, J. A.; Yao, W.; Ly, N.; Freitas, K. A.; Chen, Y. T.; Shi, Q.; Valencia, A. M.; Shifrut, E.; Kale, N.; Yost, K. E.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save

    • Cell Press – authorized name for: